OKYO – okyo pharma limited - american depositary shares (US:NASDAQ)
Stock Stats
News
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain [Yahoo! Finance]
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
OKYO Pharma Limited (NASDAQ: OKYO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
OKYO Pharma Limited (NASDAQ: OKYO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Form 6-K OKYO Pharma Ltd For: Mar 10
Form 6-K OKYO Pharma Ltd For: Feb 12
Form 6-K OKYO Pharma Ltd For: Jan 31
Form 6-K OKYO Pharma Ltd For: Jan 29
Form 6-K OKYO Pharma Ltd For: Jan 22
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.